2017 HIVMA of IDSA Clinical Practice Guideline for the Management of Chronic Pain in Patients Living With HIV.
Published Web Locationhttps://watermark.silverchair.com/cix636.pdf?token=AQECAHi208BE49Ooan9kkhW_Ercy7Dm3ZL_9Cf3qfKAc485ysgAAAcUwggHBBgkqhkiG9w0BBwagggGyMIIBrgIBADCCAacGCSqGSIb3DQEHATAeBglghkgBZQMEAS4wEQQMDcd1ZxIYYEkDpWYSAgEQgIIBeGOEcj2fhfMVip_5Y5My6SXlc1SUbKfoP4YKSqeBMhmLwOOtJHSyjV1R3M_FEVACk5tOTAN2wbrH1N9xHbiMIzzlsyZm_AqBpNLrVQ7cFVTzab6zQzqN6EOfhxETbjdgreW1SFTV6QfyYMsLHUK4xPPQhZZNAehmj_xBEHueKHJKnGJLsF0R8GhYaw_mjRCcAaWfxKkpXGMLFh0gPJ8CD01r-e1NXT1FmwUNZxwWtmymcaysstP25-IRJUorD8EfeUG2xk8f5vcIm8ZIAgtON59xNUEbVrSeGYZAw
Pain has always been an important part of human immunodeficiency virus (HIV) disease and its experience for patients. In this guideline, we review the types of chronic pain commonly seen among persons living with HIV (PLWH) and review the limited evidence base for treatment of chronic noncancer pain in this population. We also review the management of chronic pain in special populations of PLWH, including persons with substance use and mental health disorders. Finally, a general review of possible pharmacokinetic interactions is included to assist the HIV clinician in the treatment of chronic pain in this population.It is important to realize that guidelines cannot always account for individual variation among patients. They are not intended to supplant physician judgment with respect to particular patients or special clinical situations. The Infectious Diseases Society of American considers adherence to these guidelines to be voluntary, with the ultimate determination regarding their application to be made by the physician in the light of each patient's individual circumstances.